Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05874908
Other study ID # UNorthampton FAST PhD
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date October 19, 2021
Est. completion date October 19, 2025

Study information

Verified date May 2023
Source The University of Northampton
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Acute head and neck infections cause significant pain and discomfort for patients and impact on their quality of life. Effective antibiotic and surgical treatments have been developed for these infections but they are still able to develop into life-threatening diseases such as meningitis and sepsis. The direct cause of acute head and neck infections is often unknown but it has been suggested that they are due to a disturbance of the normal bacterial growing in the mouth or are from dental origin. The most common microorganisms identified from these infections in published studies are a group of bacteria known as viridans group streptococci (VGS). There are over 30 individual species of bacteria in the viridans group and VGS are difficult to identify to the level of a single species because of their variability. There is a lack of species identification within the hospital setting and this project aims to gain a deeper understanding of the microorganisms causing acute head and neck infections, focusing on identification of individual species of VGS bacteria. The investigators will analyse bacterial DNA to determine which species have been identified and will also look at patient data and clinical outcomes (eg. length of hospital stay) to determine if the species causing the infection has any effect on patients.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 150
Est. completion date October 19, 2025
Est. primary completion date October 19, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Over the age of 18 - Suffering with acute head and neck infection of Streptococci. - Samples must come from Northampton General Hospital. - Consent to participate in research with at least 24 hours of consideration. Exclusion Criteria: - Age <18 years. - Samples from other National Health Service (NHS) hospitals. - Infections from other areas of the body. - Infection identified as caused by non-streptococcal bacteria. - Chosen not to participate in research.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom University of Northampton Northampton

Sponsors (2)

Lead Sponsor Collaborator
The University of Northampton Northampton General Hospital NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Identification of Streptococci Species Identification by DNA analysis of ribosomal ribonucleic acid (rRNA) genes and biochemical testing. 4 years
Secondary Patient Characteristics Age in years. All measurements will be combined to determine common traits in acute head and neck infections. 4 Years
Secondary Patient Characteristics Sex as biological gender. All measurements will be combined to determine common traits in acute head and neck infections. 4 Years
Secondary Patient Characteristics Site of Infection in areas of the head and neck. All measurements will be combined to determine common traits in acute head and neck infections. 4 Years
Secondary Clinical Outcomes Length of hospital stay in days. All measurements will be combined to determine common traits in acute head and neck infections. 4 Years
Secondary Clinical Outcomes Antibiotic treatment in medication type. All measurements will be combined to determine common traits in acute head and neck infections. 4 Years
Secondary Clinical Outcomes Diabetic diagnosis in diabetic/non-diabetic. All measurements will be combined to determine common traits in acute head and neck infections. 4 Years
See also
  Status Clinical Trial Phase
Recruiting NCT03048513 - Clinical Presentation of Melioidosis in Head and Neck Region N/A